Healthy Diet Healthy Women

Women's health (physical and mental) is closely related (and somewhat "mimics") hormonal status and "balance" in the body.
Hormonal status here refer to the interplay between female sex hormones (estrogen and progesterone), stress hormones (specifically cortisol), and thyroid hormones (TSH, T4, T3). Sex hormone production and balance is particularly sensitive to levels of stress hormones.
Stress has a comprehensive effect on oestrogen / progesterone balance, as well as creating unnecessary inflammation in the body.

A hormonal cycle in perfect balance helps a woman to feel confident, empowered, healthy and happy. A woman who feels "out of sorts", is depressed for no apparent reason, or other common signs and symptoms of hormonal imbalance (of which there are many), is either under too much stress, not taking enough exercise, and or, is eating a poor diet. She herself is out of balance!
Eating poor results in the body not getting sufficient nutrients are necessary to produce enough of the correct hormones in the correct balance.
Nutrients often lacking including essential fatty acids (specifically GLA, EPA and DHA), B vitamins (especially B6), calcium and magnesium.

A "healthy diet for a healthy woman" should be "designed" to encourage normal healthy production, balance, detoxification and excretion of estrogen and other hormones. The organs involved are the ovaries and adrenals (for production), the liver (for detoxification), and the kidneys and bowel (for excretion via faeces and urine). Naturally, these organs need to be in good working order, and nourished correctly!
The diet should contain a wide array of antioxidants and anti-inflammatory agents to dampen any internal inflammation. It should aim to lower insulin levels (minimizing fat storage), and improve insulin sensitivity, ie the way in which the body handles sugars. This helps to burn fat, as well as minimizing excess fat being converted to estrogen.

(NB Fat cells can convert fat to a "bad" estrogen via a biochemical process called aromatisation).

Soya protein looks to encourage fat loss in the body together with an improvement in the amount of lean muscle tissue. Soya (especially soy concentrates) contains high levels of beneficial plant oestrogens … known as isoflavones. Isoflavones help to re-balance levels of good and bad oestrogens, and promote a healthier oestrogen / progesterone balance. Non-soya food sources of isoflavones include fennel, flaxseeds (ground or milled otherwise they are very indigestible), fenugreek, cumin and other spices, blueberries, and the herbs red clover, black cohosh and kudzu. Ground flaxseeds incidentally are a great "soluble" fiber source that promotes the excretion of oestrogen via faeces, and also minimizes oestrogens being re-absorbed back into the body.

Green tea "catechins" also contribute to healthy estrogen detoxification and excretion.
A diet that is rich in cruciferous vegetables and wholegrains supports healthy liver function …. specifically in the healthy detoxification of estrogen and other hormones through the liver.

Diet

The diet should be as clean as possible. This means eating food that contains NO unnecessary additives, preservatives, hormones or hormone-mimicking chemicals, sugars, or trans fats / hydrogenated fats. Eating only natural, unprocessed foods (in itself) will ensure that all these biochemically and hormonally disruptive substances are kept to an absolute minimum.

Highly beneficial foods …

Nutritional science has come a long way, and we now know that the following foods are highly beneficial for proper hormone production and healthy oestrogen metabolism.

Soya foods and soy concentrates – tofu, miso, Tamari, tempeh, soya beans, soya milk and plain soya yogurt

Chickpeas and beans in general – mung beans are easy to soak and cook in 45 mins, or sprouted

Whole and ground Indian spices and herbs – fenugreek seeds (wonderful when sprouted), cumin, cinnamon, turmeric etc

Unpolluted oily fish (and other quality fish) and fish oil – choose high-grade unpolluted fish oil capsules

WHOLE grains – brown rice, wheat berries and rye berries (these are the whole wheat and rye grains that when soaked and cooked have a lovely chewy texture), barley, millet, whole oats

Cruciferous vegetables – broccoli, cauliflower, cabbage, and Brussels sprouts

Ground / milled flaxseeds – 2 tablespoons per day

Sunflower and pumpkin seeds -preferably ground

Almonds and walnuts – preferably ground

Berry fruits (especially blueberries, raspberries, blackberries etc.), a little melon and citrus fruits such as lemons. Warm / hot water with the juice of a fresh lemon is the best way to start the day.

Highly beneficial drinks …

Organic Green tea – steep for 5-10 minutes

Miso soup – you can buy saches or just add hot water to a tsp of miso paste

Soya shakes – blend soya milk, yogurt, berries and ground seeds

Filtered water with a little lime or lemon juice – remember that urine color is an excellent indication of hydration status. It should be pale yellow / straw color the majority of the time … so drink enough water and other fluid to achieve this. Drinking sufficient water is vital for normal kidney function and excretion of oestrogen via urine.

Meal ideas …

The majority of the meals and foods I have varies contain slow-releasing carbohydrates. Slow-releasing carbohydrates (often call "complex" or low-glycaemic foods) are digested and broken down in the gut relatively slowly, releasing their sugars steadily into the bloodstream. This results in a steady rise in blood sugar, sustained energy, as well as efficient fat breakdown and hormone control. Eating complex carbohydrates help increase and control energy levels; aids weight loss, and controls and encourage a natural appetite.

NB Re: Women's health and hormone balance …

Eating natural whole foods keeps insulin levels low – high insulin increases testosterone and estrogen production leading to potential estrogen and / or testosterone dominance in relation to progesterone

Breakfast

* Berries with yogurt and cinnamon – Combine a a punnet of blueberries and a a punnet of raspberries with 100g of goat's yogurt. Mix in 2 tablespoons of ground flaxseeds and sprinkle on top t tsp of ground cinnamon.

* A small bowl of oat porridge or cooked oatmeal made with soya or almond milk (Ecomil / Evernat). Add grated apple, a handful of whole almonds, or sunflower seeds and 2 or 3 tablespoons of natural "bio" yogurt.

* Fruit bowl with yogurt and flaxseed – chop 2 pieces of fruit, top with plain soya yogurt and stir in 2 tablespoons of ground or ready-milled linseeds (flaxseeds), with a soya milk or almond milk and hot water. Add t tsp of cinnamon too.

* Smoothies in a glass – A blend of raspberries and strawberries, yogurt, soya milk or almond milk, and 2 tablespoons of milled / ground flaxseeds (available from some Sainsbury's stores or health food shops), or wheatgerm. This meal provides essential fats, protein and fiber and flaxseeds (or other seeds) add a nutty taste to the mixture. A great start to the day!

Lunch

Chickpea dahl with dark green leafy and baby vegetable salad – gently fry off t tsp each of fenugreek seeds, coriander seeds and ground cumin. Add can can of chickpeas and 100g of cherry tomatoes. Cook gently for 10-15 mins. Make a salad of green leaves, chopped coriander, and add mange tout peas, sliced ​​beetroot, cucumber, and sliced ​​raw fennel. Drizzle with a little olive oil, balsamic or cider vinegar, and a little lemon juice. Serve with a slice of rye bread.

Dinner

Tofu and cruciferous veg stir-fry. Use a variety of cruciferous vegetables – broccoli, cauliflower, cage, and stir-fry with onion, garlic and ginger. Use Tamari or a spoon of miso (try brown rice miso) mixed in a little water as a base or marinade. Stir in 100-150g of cubed tofu, tossing the mix until the vegetables are "al dente" … cooked but with a slight crunch!

Snacks if you need them …

A small hand of whole almonds

Hummus and vegetable crudités

A small bowl of sliced ​​melon, blueberries and raspberries

Do supplements help?

Coupled with a good hormone-friendly diet, supplements can further naturally balance and control hormone levels.

The following are examples of beneficial supplements for hormonal balance …

Fish Oil (containing EPA and DHA) – vital for production of healthy prostaglandins and anti-inflammatory substances in the body.

B Vitamins, taken as a "complex" – B vitamins together with EPA and DHA are paramount for healthy estrogen / progesterone balance, AND liver function.

Antioxidants such as green tea extract, d-limonene, turmeric or other quality antioxidants to support healthy cellular aging.

Other oestrogen-supporting agents – isoflavones, non-soy isoflavones, phytonutrients, active folates (supporting methylation), support female health at all stages as well as benefitting breast health, bone health and cardiovascular health.

Calcium together with other essential nutrients to support bone health – calcium must be in an absorbable form, and taken with other nutrients, such as magnesium, vitamin D and boron. Microcrystalline "hydroxyapatite" (MCHC) is the ultimate form of calcium for proper absorption into bone, and studies show this to be effective in improving bone density in postmenopausal women.

NB Always seek advice from a registered Nutritionist before embarking on a specific supplement program.

Balancing herbs can be very helpful for many women in dealing with stress or sex hormone imbalance (particularly during the pre-menstrual phase and during and after menopause). Examples include chaste berry (agnus castus), dong quai, black cohosh, red clover, ginger, evening primrose, peony root, red raspberry leaf, and St.. John's Wort.
Many can be taken in isolation, or in combination with each other.
Always get professional advise before taking herbs, especially if you are on ANY medication, or hormonal treatment.

Exercise

Yoga and Pilates are two of the best forms of exercise for women to do regularly.

Stress management – meditation, deep breathing, cognitive behavioral therapy, transactional analysis (TA), are all useful and effective therapies and practices that can benefit women in a thousand ways!

Raw Food for Dogs Chat & QnA



Shop Exotic Nutrition and use the coupon “HAPPY480” for 10% off your entire order. This code is good for one purchase per customer each month.

New Videos every week
Store & Blog
www.mjhappytails.com
Patreon
www.fb.com/mjhappytails
Instagram @Meghan_happytails

Send Happy Tails Fan Mail to:
Meghan Arriola
8900 Viscount
AN #723
El Paso, Texas 79925

Improve Penis Power With Superfoods

The foods men eat may have a pronounced effect on the health of their penis. Foods containing vitamins and minerals specific to penis health support sexual function, nerve transmission and testosterone levels when consumed regularly. While it is possible to support penis health through eating specific superfoods, it can be hard to achieve every single day. Men should eat a balanced diet, use recommended nutritional supplements, and explore penis health crèmes as ways of increasing vitamins and minerals for reproductive health.

Ginger: Ginger is a warming and invigorating plant that increases circulation to the extremities and the pelvic region, supporting healthy penile erections by improving blood flow. The root of the ginger plant is a rich source of essential oils, flavonoids and other plant chemicals, which open up blood vessels once ingested and also reduce platelet aggregation. In a study published in Food and Chemical Toxicology in 2010, researchers fed mice ginger root for 65 days. By the end of the study, the mice had increased testosterone levels, increased sperm count and motility, and increased sexual organ weight. Take ginger root as a superfood tea, purchase it as a herbal extract, or consume fresh root each day with your meals. If you are on heart or blood thinning medications, check with your doctor or pharmacist before using ginger products.

Nuts : Eat nuts for your nuts, and for your penis health. Nuts such as almonds, cashews, peanuts, brazil nuts and pecans contain dense amounts of nutrients essential for male sexual health. Magnesium for nervous system health, selenium for prostate health, protein for energy, chromium for lasting blood sugar levels, and essential fatty acids for nerve transmission. While nuts contain a variety of essential fatty acids, the most common fatty acid found in nuts is oleic acid. Nerves throughout the body, including in nerves in the penis, require oleic acid to form a protective coating around the nerve fiber. Without this protective sheath, known as myelin, nerve messages become confused and fail to transmit appropriately. Consume a small handful of mixed nuts each day to promote nerve health in your penis and boost energy levels.

Mushrooms: Mushrooms have been used for vitality, longevity and sexual health for thousands of years. While white button mushrooms are the most commonly consumed edible mushroom, the world is filled with hundreds of species of edible and medicinal mushrooms, some of which may be useful for penis health. A superfood and medicinal mushroom from the Himalayas, Cordyceps sinensis, has been extensively researched for its many health promoting properties, including sexual enhancement. Cordyceps has a positive effect on nitric oxide (NO) in the penis, acting in a similar way to the drug Viagra. It also increases testosterone levels and according to a study in 2009, Cordyceps has a beneficial effect on both sexual performance and fertility of animals. Find dried cordyceps from an Asian grocer or take Cordyceps in the form of a dried extract.

Fruits:Eating fruit may not sound very masculine, but most fruits are packed full of vitamins that will support robust sexual health. Oranges, nectarines, apples, red peppers, berries, rosehips, mangoes and kiwifruit are excellent sources of vitamin C and bioflavonoids for healthy circulation to the penis, effective connective tissue repair for the penis and foreskin, increased testosterone production, and antioxidant protection for the prostate. Tomatoes are also a source of vitamin A and lycopene for male reproductive health, and raisins contain magnesium which is essential for nervous system health. Watermelons, oranges and avocados contain the amino acid arginine, which supports erectile health and sexual performance. Eat a wide variety of fruits each day to benefit from their nutritional support.

Enhancing Penis Health with Nutrition

Vitamins, minerals and antioxidants are important for penis health and male virility. While there are many superfoods and herbal remedies out there which support the health of the male reproductive system, the best method to support penis health is always to eat a balanced and diverse diet. If you are on any medications or have health concerns, check with your pharmacist or other health professional for advice.

For increased nutritional support many men consider taking multivitamins and minerals. These Supplements are broken down and absorbed in the digestive tract to varying degrees in different individuals, but you can use a penis health formula (most health professionals recommend Man1 Man Oil) containing vitamin C, vitamin A, arginine and natural oils. Penis health formulas carry nutrients directly into the local blood stream, enhancing sexual function, connective tissue health and testosterone production quickly.

5/20 WWE Raw Results: Powell’s review of WWE Money in the Bank fallout with men’s winner Brock Lesnar, Mick Foley introduces a new WWE title belt

By Jason Powell, ProWrestling.net Editor (@prowrestlingnet)

WWE Raw on the USA Network
Aired live on May 20, 2019 from Albany, New York at Times Union Center

[Hour One] Michael Cole welcomed viewers to the show and was joined on commentary by Corey Graves and Renee Young. Mike Rome was the ring announcer…

Brock Lesnar’s music played and he walked out while holding the Money in the Bank briefcase before passing it off to Paul Heyman. Cole said Lesnar may have pulled off the biggest shocker in the history of MITB. A recap video aired of Lesnar winning the men’s MITB ladder match. Lesnar took the briefcase back and acted like he was listening to a boombox (a/k/a a portable radio for some of you younger readers).

Heyman said that if he were the WWE Champion or WWE Universal Champion, he’d be a very paranoid man right now. Heyman said they are vulnerable to the greatest assassin in WWE history who now has a contract on their title reign. He said Seth Rollins has to be paranoid whenever he enters an arena because Lesnar could strike at any time.

WWE Universal Champion Seth Rollins made his entrance while Cole noted that he defeated AJ Styles at MITB. Lesnar and Heyman laughed when Rollins entered the ring. Rollins said he should be ecstatic that he won the fight of his life over Styles. Rollins said he’s not in a good mood because he has to come out and see Lesnar holding the MITB contract. Rollins said he’s trying to be a champion to inspire people and to be the type of champion that Lesnar never had the guts to be.

Rollins said he beat Lesnar at WrestleMania and he’s sure he can beat him again, but he doesn’t want to wait around to find out. Rollins encouraged Lesnar to cash in his contract tonight and face him for the championship on the spot. Lesnar went face to face with Rollins. Heyman said it’s a game of patience and Rollins has to wait until Lesnar feels like cashing in the contract.

Heyman said Rollins should be used to waiting because he waited around seven hours at WrestleMania to see his girlfriend main event the show. Rollins stepped forward and Lesnar cut him off, which led to the two of them jawing at one another. Heyman pulled Lesnar back and asked Rollins who said he’s even worthy to face Lesnar again. Heyman said it might be a new day and perhaps they are envisioning Lesnar vs. Kofi Kingston.

The New Day entrance theme played and WWE Champion Kofi Kingston made his entrance. The broadcast team noted that the wild card rules are in effect. Kingston told Rollins that he wasn’t trying to steal his thunder, he was trying to establish his legacy as WWE Champion. Kingston said he wants to be remembered as the best WWE Champion of all time and he can’t do that unless he faces the best night after night. Kingston told Lesnar that if he cashes in tonight, he needs him to cash in on him.

Heyman said the WWE Universal Champion and the WWE Champion were auditioning to defend their title against the reigning and defending heavyweight champion of the box office. Heyman said the MITB winner didn’t have to come to them, they came to him. Heyman said he had inside word that Rollins and Kingston weren’t finished this evening. Heyman teased that Lesnar and the MITB contract aren’t going anywhere. “Stay tuned, The Beast is yet to come,” Heyman concluded to end the segment…

Powell’s POV: A very strong segment to open the show. I’m not a fan of Lesnar’s surprise MITB win, but they played this perfectly by teasing that he could cash in on either champion tonight. Heyman’s mic work was solid and I like that both babyface champions stepped up and encouraged Lesnar to cash in tonight. My guess is that this leads to nothing more than a tease, but it’s still a nice hook for the remainder of the show.

Mick Foley arrived in the parking lot carrying a title belt in a case. He was greeted by Zack Ryder, Curt Hawkins, Titus O’Neil, Dana Brooke, and Drake Maverick…

Backstage, Sami Zayn asked Bobby Lashley to help him since he knows Lashley is facing Braun Strowman in a couple weeks. Lashley rejected his request and wished him luck. Sami Zayn made his entrance and sold rib pain from the attack at MITB. Braun Strowman was shown staring into a camera backstage. Cole said Strowman vs. Zayn was coming up after the break… [C]

Rollins and Kingston talked as they walked backstage where they ran into Triple H, who booked them in the tag team main event against Bobby Lashley and Baron Corbin…

Powell’s POV: I like the idea of saving Rollins and Kingston’s tag match for the main event, but what will it take for them to realize that viewers are not buy Corbin as a main eventer?

Braun Strowman made his entrance. Zayn ran and Strowman chased him backstage. Strowman approached Lashley backstage, then Zayn sucker punched Strowman. Braun got the better of Zayn immediately, then told Lashley he’d deal with him later. Strowman went after Zayn and ended up carrying him back onto the stage and down to ringside. Zayn slipped away and ran Strowman into the ring post twice. Zayn tried to do it a third time, but Strowman tossed him into the barricade.

1. Braun Strowman vs. Sami Zayn. Strowman charged Zayn, who moved, causing Strowman to crash into the corner of the ring. The referee called for the bell. Zayn set up for his Helluva Kick finisher, but Strowman clotheslined him. Strowman followed up with a running powerslam and pinned Zayn…

Braun Strowman defeated Sami Zayn in 0:45.

Powell’s POV: Zayn is a terrific pest heel, but WWE already has a pest heel who always gets put in his place (see Elias). In other words, I wish they would have stretched this out by giving Zayn another fluke win over Strowman rather than giving Strowman his revenge so quickly.

Alexa Bliss and Nikki Cross were shown talking backstage while Graves hyped A Moment of Bliss with Becky Lynch as his guest… Lars Sullivan was shown walking backstage. Cole hyped Sullivan speaking in the ring for the first time for after the break… [C]

Charly Caruso stood in the ring and introduced Lars Sullivan for an exclusive interview. Sullivan walked to the ring while Cole referred to him as one of the most destructive forces in the history of WWE. Once Sullivan was in the ring, Caruso set up a video package on his “path of destruction” that was shown on the big screen. Caruso asked Sullivan what his goals are in WWE.

The Lucha House Party entrance theme played before Sullivan could answer. Kalisto, Lince Dorado, and Gran Metalik came to the ring and performed multiple dropkicks. A triple dropkick cleared Sullivan from the ring. Kalisto dove onto Sullivan, who caught him and slammed him on the apron. Dorado and Metalik dove at Sullivan and he stumbled, then regrouped and roughed up both men. Sullivan set up for a powerbomb on Dorado, but Kalisto and Metalik grabbed Dorado and pulled him to ringside. Sullivan’s music played while the LHP trio backed up the ramp…

A video package recapped Rollins defeating AJ Styles to retain the WWE Universal Championship at MITB… AJ Styles was shown talking with a production crew member backstage. Cole said Styles would be featured in an interview coming up shortly…

Ricochet made his entrance for a match against Cesaro… [C] Footage aired of Ricochet crashing through a ladder at MITB. New footage aired of Cesaro approaching Ricochet in the trainer’s area and mocking him for hurting. Ricochet said he would do it again. Cesaro told him to smarten up…

2. Cesaro vs. Ricochet. Cesaro came out to new entrance music. Ricochet had his back heavily taped, and Cesaro tried to exploit the injury. [C] Ricochet rallied and they went to a split screen ad for roughly 10 seconds while he performed a flip dive onto Cesaro. Ricochet went for a top rope move and ended up eating an uppercut. Cesaro followed up with a nice backbreaker and a Neutralizer that led to him scoring the clean pin. Ricochet continued to sell his back injury afterward…

Cesaro pinned Ricochet in 6:50.

Powell’s POV: A good match and a nice win for Cesaro. Meanwhile, Ricochet had the out for losing the match due to the injuries he played up going into the match, and the broadcast team did a good job of framing this as a ballsy outing despite the loss.

AJ Styles was interviewed by Caruso backstage. Styles said he lost, but he feels he can beat him. Baron Corbin clapped as he walked onto the interview set. Corbin taunted Styles for failing. Styles pointed out that Corbin squandered his MITB contract and was fired as general manager. Corbin noted that he pinned Rollins on Raw and was bothered got the title match instead of him. Corbin referred to it as a slap in the face. Styles gave him a real slap in the face. Corbin told Styles he’d pay for it…

Roman Reigns made his entrance… [C]

[Hour Two] Mick Foley was shown talking with Kofi Kingston in the backstage area…

Reigns stood in the ring. Before he could speak, Shane McMahon’s entrance music played. Shane danced onto the stage with a mic. Shane said Reigns was using the wild card rule. Shane boasted that he’s the best in the world. He said he won a brutal cage match and now he’s finished with The Miz. Shane said he’s turning his attention to Reigns because he can’t get out of his mind what Reigns did to Vince McMahon.

Reigns said he hates spoiled rich kids. He said Shane is done with Miz and he’s finished with Elias. Shane said Reigns isn’t finished with Elias. Reigns said that since he didn’t see Elias, he and Shane could meet in the ring. Shane said Reigns was making the challenge because he knows Shane was in the brutal cage match. Shane left it up to the crowd, which cheered the tease of Shane vs. Reigns.

“Well, that’s not happening tonight,” Shane said. He added that he does what all spoiled rich kids do – what he wants and when he wants. Shane said he’s in control and offered to show Reigns what control is. McMahon introduced Drew McIntyre, who came out and stood next to Shane on the stage. Shane announced that he will face Reigns at WWE Super ShowDown…

Powell’s POV: I guess the idea is that Shane has hired McIntyre to be his muscle? It wasn’t made very clear, but I assume this means McIntyre will be in Shane’s corner at Super ShowDown.

A shot aired of Becky Lynch looking at the Raw Women’s Championship belt while Graves hyped her appearance on Alexa Bliss’s talkshow… Brock Lesnar and Paul Heyman were shown backstage. Heyman was cleaning the MITB briefcase… The Usos made their entrance for a match against The Revival… [C] A Smackdown ad hyped Big E’s welcome back celebration, and Roman Reigns vs. Elias…

Backstage, Shane was asked about insinuating that McIntyre would be with him at Super ShowDown. Shane said he wasn’t insinuating anything. The Miz showed up and asked Shane if he really thinks he’s done with him. McIntyre said that if Miz had a problem with Shane then has a problem with him. Miz said that once he finished with McIntyre he was coming after Shane again…

3. Jimmy Uso and Jey Uso vs. “The Revival” Scott Dawson and Dash Wilder. Prior to the match, footage aired of the back shaving and Ucey Hot nonsense. The Revival attacked one of the Usos and ran him into the barricade. Cole wasn’t sure if the bell rang, but the ref counted an early pin attempt, so the match was underway. The Usos got took control going into a break. [C]

Dawson tagged himself in. Wilder powerbombed Jey, then Dawson performed a top rope elbow drop that led to a two count. The teams traded more near falls. A “this is awesome” chant broke out. In the end, Dawson rolled up Jimmy and held his tights while getting the win…

The Revival defeated The Usos in 10:40.

Powell’s POV: It’s crazy that Cole kept talking about the back shaving and Ucey Hot bits throughout the match. It’s as if no one in WWE realizes that it made the Usos look like dicks even though they are the babyface characters. The match was entertaining, but I just couldn’t shake the feeling that the first Raw match between these teams could have been so much bigger with a real build rather than the humiliating sports entertainment garbage.

Backstage, Alexa Bliss told Nikki Cross that she did a good job of replacing her in the MITB ladder match, but the problem is that she didn’t win. Bliss said it’s okay because she has her own show. The Revival entered the picture and celebrated their win in an over the top way. Wilder said they should be on A Moment of Bliss…

Cole hyped the FireFly Fun House segment for after the break… [C]

How Big Pharmas Simultaneously Repel And Embrace Innovation

review of Sirio Maccioni’s elegant Manhattan restaurant Le Cirque (which closed, at least temporarily, in January 2018). Riechl described two distinct experiences she had at the establishment, first as an anonymous diner, then as a recognized Times food critic; in the first instance, she received a bad seat after a long wait, was treated rudely, then served food that was (relatively) mediocre. But once she was recognized as a VIP, she was duly treated like royalty – felicitous seating, solicitous service, and sublime food. In presenting these experiences together, Riechl highlighted both the typical meal experience of most diners as well as the transcendent experience that was possible. (I went to Le Cirque in the mid-80s to celebrate my high school graduation, in my pre-low-carb days; while I can’t remember where we sat, the food, particularly the legendary potato-wrapped bass, was delicious).

Legendary restauranteur Sirio Maccioni, in a 2014 photo.  According to New York Times critic Ruth Riechl, Maccioni’s Le Cirque could provide diners with average or exceptional culinary experiences, depending on their circumstances.  Aspiring innovators in large pharma companies report similarly disparate treatment.  (Photo by Andy Kropa/Invision/AP)

Andy Kropa /Invision/AP

It occurred to me that in many ways, innovation at large pharmas can be experienced very similarly – so often, disappointing and stifling, but occasionally, under the right circumstances, transformative and elating.

This dual-nature of pharma innovation may explain both why so many innovators are repelled by large pharma companies, yet some – including those focused on digital and data – are deliberately seeking out opportunities in these corporations.

In contrast to big drug companies, the appeal of startups is easy to understand – the self-actualization, the sense that your individual contribution not only matters but is essential, the feeling of David vs Goliath, the allure of significant upside, both in terms of impact (disruption, making the world a better place, etc.) and financial return.   You can really get a good feel for this by watching the HBO Theranos movie, The Inventor, where you can see how so many people were drawn to the startup for this powerful combination of reasons. According to this documentary at least, Theranos offered all these elements, lacking only an actual, functional product and an achievable plan to create one.  (My thoughts on Carreyrou’s Theranos book, Bad Blood, are here.)

What’s interesting to me is the increasing number of well-trained, innovative people I seem to be running into, particularly on the digital and data side, who are coming to large companies after spending time in health tech startups, not because they’ve somehow given up on their dreams, but rather because, in some ways, they’re more serious about them, and are seeking more than the superficial accouterments of tech startups (so brutally described in Disrupted, by Dan Lyons). Moreover, these innovators are joining large companies with eyes wide open; they recognize the very real, and highly problematic challenges large companies have with agility and decision-making. Nevertheless, it seems like these innovators (at least the few I’ve met) hunger for the chance to really make a difference in the application of tech to health and drug discovery and development, to work towards a result not twitter-worthy but FDA-worthy, in the context of a well-resourced and credible organization capable of responsibly delivering it.

(Disclosure/reminder: as a corporate VC, I arguably have a foot in both pharma and startup camps.)

The Bad News

First, the bad news. The equivalent to entering Le Cirque as an anonymous patron in 1993 is joining pharma and trying to innovate against the grain. Everything is arrayed against you.

Large organizations tend to be remarkably risk-adverse, essentially because they have an established, successful enterprise and generally worry more about the downside risk of any given opportunity then the upside possibility it could represent. The implicit calculation is pretty simple: one screw-up could bring the whole organization down, while one striking success is unlikely to move the needle all that much. In contrast, startups tend to have very little to lose, and if they’re lucky and/or good, a lot to gain – hence their view of risk is quite different.

To be sure, in most large organizations, no one wants to inhibit innovation — at least not explicitly. Innovation, like failure, is something to publicly cherish and visibly celebrate – the kind of thing that’s abstractly good for an organization to value, but generally not needed or welcome in your operational group, where you’re already plenty busy trying to get defined tasks completed, thank you very much.

But even if you’re skeptical about innovative proposals, to operate successfully in large, highly matrixed organization, you need to maintain generally cordial relationships with as many people as possible. The result is what I first wrote about in 2011, when a senior pharma executive who had recently transitioned to industry from a top Harvard hospital remarked to me that:

“his greatest shock upon joining the business world, the thing he was least prepared for, wasn’t the business vocabulary, the timelines, the quarterly expectations of wall street analysts – none of the above.  Instead, it was dealing with the passive aggressive behavior he discovered everywhere around him.”

It’s a phenomenon I’ve described as “innovation dissipation,” where no one explicitly says “no” to a new idea, it just winds up ping-ponging through an organization until it eventually peters out.

Recently, a colleague offered what I thought was an astute explanation for this phenomenon: “Why spend political capital saying ‘no?’” he asked me. He’s right. The savviest, most senior players in complex organizations seem especially adept at this, politely taking meetings and pursing their lips while listening thoughtfully, and then suggesting several follow-up meetings they know full well aren’t likely to lead anywhere.

It turns out, there’s even a phrase for this mindset: “trust the process.” This may not have started out as cynical in spirit, but in practice, in a large organization, it basically means let the process play out, and don’t try to rock the boat by interfering. The result – as Safi Bahcall brutally describes in Loonshots (my WSJ review here, and my more detailed discussion of this exact point here) – is a culture where everyone is highly attuned to the (perceived) views of those at the apex of the hierarchy, and original, orthogonal, or non-incremental perspectives will struggle to be heard. That’s the system, and often the fate of bottom-up innovation within it.

At this point, would be innovators out there might be ready to don their airbirds, sling their Herschel backpacks over their shoulders, grab their Sightglass lattes, and head off the to closest WeWork.

Not so fast. I’ve recently spoken with several health tech innovators who actually did something more or less like this early in their careers, then quite deliberately choose to take their talents to large pharma companies with many of the liabilities enumerated above. What were they thinking?

The Good News: The Three Rs

Turns out that like, like VIPs dining at Le Cirque, innovators who find themselves aligned with and integrated into pharma strategy may be treated to an exceptional experience. According to several such well-situated innovators, large, incumbent companies have a lot going for them; in particular: resources, redundancy, and results.

The resource aspect is fairly obvious: when a large company truly commits to a particular strategy, approach, or technology, they are able to pursue this goal in a deep, remarkably thorough way, deploying people, capital, and leveraging (as well as acquiring) institutional know-how. Example: a few months ago, I heard a senior pharma oncology leader describe the way they were approaching a particular category of high-priority targets, and it was mind-blowing in scope, staggeringly comprehensive. Multiple options were systematically evaluated at almost every step in the process – truly the “mutually exclusive, collectively exhaustive (MECE)” concept applied to a particular area of biological discovery. Offerings from many startups were considered at each of these stages, and it was hard not to be struck by the observation that while a small company could potentially optimize one particular solution or approach, the large pharma could effectively afford to choose from among these to pick the best one.

The second, often underappreciated aspect that several innovators kept returning to is the redundancy and depth you see in big pharma; I was regaled with stories of how, in startups, you often have only a single person in a key area like legal or regulatory, and you are disproportionately dependent on their expertise, not only in terms of what they know, but also their ability to recognize their own gaps. Obviously, there is a huge emphasis in startups in hiring excellent people, but in many ways, startups operate largely without a net, a precarious situation which can, and often does, prove disastrous to young companies.

The last, and in some ways most important difference between startups and large companies is that at the end of the day, many startups just need to look promising enough to justify an acquisition or an IPO – sizzle with the promise of steak. But at a large company, the buck stops with you in many ways; your business depends not on the glamor or glitz of an emerging technology, but on actually getting it to work, and getting it to market. Thus a buzzy startup like Stemcentrx could make billions for its investors, yet ultimately fail in the hands of the pharma company who acquired it and tried to bring the products to market. The jury still seems to be out for the early CAR-T companies (including Juno, acquired by Celgene [itself acquired by BMS], and Kite, acquired by Gilead). (Disclosure: my wife works at Gilead though not in oncology.)

Just as academia tends to attract researchers who pursue novel science, and biotech startups often attract researchers keen to turn raw science into promising therapeutics, pharma attracts many researchers with the determination and patience to see raw science and promising therapeutics through to approval and into the clinic. Their mission is achieving clinical impact at scale, and it’s a powerful draw for some innovators.

Bottom Line

Pharmas are attractive for innovators pursuing approaches that are strongly endorsed by senior leadership and reasonably welcomed by the operational areas of the organization. The way some pharmas are working through the complex supply-chain logistics required for delivering CAR-T therapy or gene therapy at scale offer striking examples.

On the other hand, pharma organizations generally prioritize caution over agility, and incremental change over radical new approaches. Thus even innovation welcomed by the C-suite (like a lot of the original digital and data efforts) can run into the grindstone when those in the trenches can’t see the benefit, and experience only burden.

In general, large pharmas, like other big companies, are likely to remain generally resistant to profound innovation, though they will embrace and really go after specific opportunities they view as adequately validated or promising. Such traction requires explicitly endorsement and constant, active support from the top echelons of management if the approach is to even have a chance. Meanwhile, detached innovation initiatives reliably garner transient publicity but tend to achieve little durable organizational impact.

There’s likely a considerable opportunity to harness the many bottom-up innovative ideas to which pharma seems constitutively unable to respond; the robust startup ecosystem offers an attractive alternative or salvage pathway for some but not all of these promising approaches.

“>

In 1993, Ruth Riechl, the new restaurant critic for the New York Times, penned a memorable review of Sirio Maccioni’s elegant Manhattan restaurant Le Cirque (which closed, at least temporarily, in January 2018). Riechl described two distinct experiences she had at the establishment, first as an anonymous diner, then as a recognized Times food critic; in the first instance, she received a bad seat after a long wait, was treated rudely, then served food that was (relatively) mediocre. But once she was recognized as a VIP, she was duly treated like royalty – felicitous seating, solicitous service, and sublime food. In presenting these experiences together, Riechl highlighted both the typical meal experience of most diners as well as the transcendent experience that was possible. (I went to Le Cirque in the mid-80s to celebrate my high school graduation, in my pre-low-carb days; while I can’t remember where we sat, the food, particularly the legendary potato-wrapped bass, was delicious).

Legendary restauranteur Sirio Maccioni, in a 2014 photo.  According to New York Times critic Ruth Riechl, Maccioni’s Le Cirque could provide diners with average or exceptional culinary experiences, depending on their circumstances.  Aspiring innovators in large pharma companies report similarly disparate treatment.  (Photo by Andy Kropa/Invision/AP)

Andy Kropa /Invision/AP

It occurred to me that in many ways, innovation at large pharmas can be experienced very similarly – so often, disappointing and stifling, but occasionally, under the right circumstances, transformative and elating.

This dual-nature of pharma innovation may explain both why so many innovators are repelled by large pharma companies, yet some – including those focused on digital and data – are deliberately seeking out opportunities in these corporations.

In contrast to big drug companies, the appeal of startups is easy to understand – the self-actualization, the sense that your individual contribution not only matters but is essential, the feeling of David vs Goliath, the allure of significant upside, both in terms of impact (disruption, making the world a better place, etc.) and financial return.   You can really get a good feel for this by watching the HBO Theranos movie, The Inventor, where you can see how so many people were drawn to the startup for this powerful combination of reasons. According to this documentary at least, Theranos offered all these elements, lacking only an actual, functional product and an achievable plan to create one.  (My thoughts on Carreyrou’s Theranos book, Bad Blood, are here.)

What’s interesting to me is the increasing number of well-trained, innovative people I seem to be running into, particularly on the digital and data side, who are coming to large companies after spending time in health tech startups, not because they’ve somehow given up on their dreams, but rather because, in some ways, they’re more serious about them, and are seeking more than the superficial accouterments of tech startups (so brutally described in Disrupted, by Dan Lyons). Moreover, these innovators are joining large companies with eyes wide open; they recognize the very real, and highly problematic challenges large companies have with agility and decision-making. Nevertheless, it seems like these innovators (at least the few I’ve met) hunger for the chance to really make a difference in the application of tech to health and drug discovery and development, to work towards a result not twitter-worthy but FDA-worthy, in the context of a well-resourced and credible organization capable of responsibly delivering it.

(Disclosure/reminder: as a corporate VC, I arguably have a foot in both pharma and startup camps.)

The Bad News

First, the bad news. The equivalent to entering Le Cirque as an anonymous patron in 1993 is joining pharma and trying to innovate against the grain. Everything is arrayed against you.

Large organizations tend to be remarkably risk-adverse, essentially because they have an established, successful enterprise and generally worry more about the downside risk of any given opportunity then the upside possibility it could represent. The implicit calculation is pretty simple: one screw-up could bring the whole organization down, while one striking success is unlikely to move the needle all that much. In contrast, startups tend to have very little to lose, and if they’re lucky and/or good, a lot to gain – hence their view of risk is quite different.

To be sure, in most large organizations, no one wants to inhibit innovation — at least not explicitly. Innovation, like failure, is something to publicly cherish and visibly celebrate – the kind of thing that’s abstractly good for an organization to value, but generally not needed or welcome in your operational group, where you’re already plenty busy trying to get defined tasks completed, thank you very much.

But even if you’re skeptical about innovative proposals, to operate successfully in large, highly matrixed organization, you need to maintain generally cordial relationships with as many people as possible. The result is what I first wrote about in 2011, when a senior pharma executive who had recently transitioned to industry from a top Harvard hospital remarked to me that:

“his greatest shock upon joining the business world, the thing he was least prepared for, wasn’t the business vocabulary, the timelines, the quarterly expectations of wall street analysts – none of the above.  Instead, it was dealing with the passive aggressive behavior he discovered everywhere around him.”

It’s a phenomenon I’ve described as “innovation dissipation,” where no one explicitly says “no” to a new idea, it just winds up ping-ponging through an organization until it eventually peters out.

Recently, a colleague offered what I thought was an astute explanation for this phenomenon: “Why spend political capital saying ‘no?’” he asked me. He’s right. The savviest, most senior players in complex organizations seem especially adept at this, politely taking meetings and pursing their lips while listening thoughtfully, and then suggesting several follow-up meetings they know full well aren’t likely to lead anywhere.

It turns out, there’s even a phrase for this mindset: “trust the process.” This may not have started out as cynical in spirit, but in practice, in a large organization, it basically means let the process play out, and don’t try to rock the boat by interfering. The result – as Safi Bahcall brutally describes in Loonshots (my WSJ review here, and my more detailed discussion of this exact point here) – is a culture where everyone is highly attuned to the (perceived) views of those at the apex of the hierarchy, and original, orthogonal, or non-incremental perspectives will struggle to be heard. That’s the system, and often the fate of bottom-up innovation within it.

At this point, would be innovators out there might be ready to don their airbirds, sling their Herschel backpacks over their shoulders, grab their Sightglass lattes, and head off the to closest WeWork.

Not so fast. I’ve recently spoken with several health tech innovators who actually did something more or less like this early in their careers, then quite deliberately choose to take their talents to large pharma companies with many of the liabilities enumerated above. What were they thinking?

The Good News: The Three Rs

Turns out that like, like VIPs dining at Le Cirque, innovators who find themselves aligned with and integrated into pharma strategy may be treated to an exceptional experience. According to several such well-situated innovators, large, incumbent companies have a lot going for them; in particular: resources, redundancy, and results.

The resource aspect is fairly obvious: when a large company truly commits to a particular strategy, approach, or technology, they are able to pursue this goal in a deep, remarkably thorough way, deploying people, capital, and leveraging (as well as acquiring) institutional know-how. Example: a few months ago, I heard a senior pharma oncology leader describe the way they were approaching a particular category of high-priority targets, and it was mind-blowing in scope, staggeringly comprehensive. Multiple options were systematically evaluated at almost every step in the process – truly the “mutually exclusive, collectively exhaustive (MECE)” concept applied to a particular area of biological discovery. Offerings from many startups were considered at each of these stages, and it was hard not to be struck by the observation that while a small company could potentially optimize one particular solution or approach, the large pharma could effectively afford to choose from among these to pick the best one.

The second, often underappreciated aspect that several innovators kept returning to is the redundancy and depth you see in big pharma; I was regaled with stories of how, in startups, you often have only a single person in a key area like legal or regulatory, and you are disproportionately dependent on their expertise, not only in terms of what they know, but also their ability to recognize their own gaps. Obviously, there is a huge emphasis in startups in hiring excellent people, but in many ways, startups operate largely without a net, a precarious situation which can, and often does, prove disastrous to young companies.

The last, and in some ways most important difference between startups and large companies is that at the end of the day, many startups just need to look promising enough to justify an acquisition or an IPO – sizzle with the promise of steak. But at a large company, the buck stops with you in many ways; your business depends not on the glamor or glitz of an emerging technology, but on actually getting it to work, and getting it to market. Thus a buzzy startup like Stemcentrx could make billions for its investors, yet ultimately fail in the hands of the pharma company who acquired it and tried to bring the products to market. The jury still seems to be out for the early CAR-T companies (including Juno, acquired by Celgene [itself acquired by BMS], and Kite, acquired by Gilead). (Disclosure: my wife works at Gilead though not in oncology.)

Just as academia tends to attract researchers who pursue novel science, and biotech startups often attract researchers keen to turn raw science into promising therapeutics, pharma attracts many researchers with the determination and patience to see raw science and promising therapeutics through to approval and into the clinic. Their mission is achieving clinical impact at scale, and it’s a powerful draw for some innovators.

Bottom Line

Pharmas are attractive for innovators pursuing approaches that are strongly endorsed by senior leadership and reasonably welcomed by the operational areas of the organization. The way some pharmas are working through the complex supply-chain logistics required for delivering CAR-T therapy or gene therapy at scale offer striking examples.

On the other hand, pharma organizations generally prioritize caution over agility, and incremental change over radical new approaches. Thus even innovation welcomed by the C-suite (like a lot of the original digital and data efforts) can run into the grindstone when those in the trenches can’t see the benefit, and experience only burden.

In general, large pharmas, like other big companies, are likely to remain generally resistant to profound innovation, though they will embrace and really go after specific opportunities they view as adequately validated or promising. Such traction requires explicitly endorsement and constant, active support from the top echelons of management if the approach is to even have a chance. Meanwhile, detached innovation initiatives reliably garner transient publicity but tend to achieve little durable organizational impact.

There’s likely a considerable opportunity to harness the many bottom-up innovative ideas to which pharma seems constitutively unable to respond; the robust startup ecosystem offers an attractive alternative or salvage pathway for some but not all of these promising approaches.

How to Lower Uric Acid in the Body Using Diet Food Supplements

Gout is caused by high uric acid in the body which produces urate crystals in the joints. So gout sufferers need to lower their uric acid levels. There are many natural ways to do this, but here, I'm going to discuss the use of dietary food supplements.

One of the first things that a gout victim is encouraged to do is to change to a low purine diet which generally speaking, means avoiding foods high in protein. eg, red meat (particularly organ meat), poultry, fish, and shellfish.

Although this is effective in helping to combat gout, the new diet period is invariably deficient in several important vitamins, minerals and nutrients, etc.

However, a sensible intake of dietary supplements can make up this shortfall and so help to maintain good overall health. This is important because poor health and a poor immune system will actually make the gout condition worse.

In addition, studies have found that some supplements can affect directly on the condition itself by being able to reduce uric acid in the body, as well as helping to reduce the pain and inflammation of an attack.

So supplementation, when applied correctly according to the individual's specific needs, can be a powerful weapon against gout as well as a means of maintaining good health.

[NB Consult your doctor before using any dietary supplements.]

Lowering Uric Acid in the Body with Diet Food Supplements

Here are 7 supplements to help reduce uric acid in the body and maintain overall good health: –

1. Vitamin B Complex

Sufficient B vitamins, specifically B5, are required to help the body excrete uric acid. Gout often follows a period of high stress and stress is a common cause of low vitamin B. This is why gout patients are often deficient in the B vitamins.

2. Vitamin C

Vitamin C has been shown to greatly reduce uric acid levels in the body. It's also great for combating stress, which many gout victims suffer from. Since stress can contribute to the condition as described above this is an important vitamin in the fight against gout.

3. Vitamin E

Low purine diets are particularly deficient in this vitamin. So, when on such a diet, the gout sufferer will need to make up for that deficiency through supplementation.

4. Fish Oil (eg Cod Liver Oil)

Research has shown that joint inflammation and even some cartilage damage can be reduced through the use of fish oil.

5. Tissue Salts (eg Silica)

These can help prevent urate crystals forming in the joints.

6. L-Glutathione

L-Glutathione is a powerful antioxidant and helps the renal system excrete acid out of the body thereby reducing uric acid levels.

7. Glucosamine

Some fairly recent studies have shown that Glucosamine can rehabilitate cartilage and reduce inflammation and pain.

You can see that diet supplementation is an important element in lowering uric acid and beating gout. But it's only one element. Others, such as diet and lifestyle changes, have to be included too.

Rational Approach to Raw Food Diet



Starting the week with a rational approach to a raw food diet. Common sense help a lot on your plant based diet with a little education on the raw vegan lifestyle.
Facebook Group:

Raw Tropical Living Gear:
Raw Vegan Fruit Lover:

Vegan for Everything T-Shirt:

www.rawtropicalliving.com
Email: [email protected]
Facebook Page:
Instagram: Jack Albritton rawtropicalliving

How To Understand Food Date Stamps

When shopping for food, date stamps are a familiar sight on almost every product. Their purpose, as described by the Department for Environment, Food and Rural Affairs, is simple: 'to help consumers make safe and optimum use of food'. Recognizing the importance of using these date stamps is essential, particularly in a commercial kitchen, because the need to prevent food poisoning is so great.

Despite this need, many sites fail to use date stamps properly. Everything in the fridge should be clearly labeled so that others know when it was opened, when it needs to be consumed by and whether it can be reheated. Leaving everything to memory runs the risk of confusion, especially if there are a lot of people involved in food preparation and handling. Therefore, a central part in stopping the threat of food poisoning is to clearly label products, whether they are used as ingredients in the business or as the product for sale or service. There are various systems in use and different rules apply for which type of labeling should be used, and when it should be used. Some important rules are listed below.

The 'use by' label can sometimes be confused by those who think that it reflects the date by which food should be eaten. This is often the case, although the 'use by' date can be extended if it is possible to freeze the food. As long as the product is frozen before the time stated, then it will still be safe to eat after the date on the package. However, it is always essential that the packet instructions on cooking, storing and freezing are adhered to. High-risk, highly perishable foods such as cooked meat, fish and dairy products must be marked with a 'use by' date in order to ensure that the food is not eaten after bacterial growth has reached a dangerously high level such that it poses a threat to human health.

'Best before' labels are less an indication of safety and more a guide of quality. They only offer an effective guide if storage instructions have been followed carefully. Eggs are a slight exception because, although they are marked with a 'best before' date, they should also be eaten by that time otherwise the level of salmonella could be health-threatening. 'Best before' labels are often displayed on less perishable items such as frozen food, dried fruit, flour, cereals, cakes and cans.

The 'display until' date is a label intended more for the seller than the consumer. 'Sell by' labels also give the same information and both can be used by stock controllers to ensure that the food is safe to sell. Using 'display until' labeling is not a legal requirement however, and DEFRA actually encourages businesses to explore alternative practices for using stock control dates which make them less visible to consumers. This is because they believe that doing so will avoid any confusion between the 'display until' and the 'use by' date; the latter is the date that is the legal requirement and is of more significance to the customer.

It is essential to label food with an indication of when it is safe to consume. The system in place should be consistent to avoid any confusion, particularly in a commercial environment, and most importantly, everyone must adhere to the date marks. It is illegal to change a date mark without re-treating or processing the food correctly, because once something is opened, it is exposed to moisture, heat, nutrients and time, all of which are requirements for bacterial growth. Products should always be stored and used according to strict guidelines to avoid any microbiological danger.

Raw Food Builds Incredible Muscle in Dogs – Magi's Slow Motion Mukbang



Magi eats a RAW turkey carcass in slow motion while showing off here muscular RAW food diet physique. Magi is a 11 month old Renascence Bulldogge.

If you’d like to see her athleticism and her muscular physique in action watch this video…

** DISCLAIMER **
“I’m just some guy on YouTube.” I am not a “professional” dog trainer nor K9 nutritionist and I am not representing myself as one. I am here just showing what ‘I do’ and what ‘works for me’ as a long time Animal Warden, breeder and dog rescuer and I explain while doing it why I do it this way. 🙂

* Before asking me any feeding questions in the comments (OR ON INSTAGRAM) look through the several links I am providing below. 99.9% of any RAW feeding questions you have for me will be answered expertly in those links in more detail than I can provide in the video comments. 🙂

*To answer a question I know I will get in the comments:

* Yes, it’s OK to feed your dogs ‘RAW’ bones. It’s only cooked bone you should never feed your dogs – Cooking the bone makes it undigested, brittle and prone to causing obstruction of the g-track and a perforated bowel. Canines are meant to digest raw bones and have been doing it for millions of years. Don’t take my word for it though, I’m just some guy on YouTube… lol. Do your research. I’ll provide some links down below if you’d like to do that. I’ve been feeding this way for over 20 years with great results.

* Yes, my dogs live in the house.

* Muk-bang or mukbang is an online broadcast in which a host eats large quantities of food, while interacting with their audience. Usually done through a webcast.

* I feed my dogs the B.A.R.F. Diet (Biologically Appropriate Raw Foods). Here are a couple of books on the B.A.R.F. diet I recommend by DVM Ian Billinghurst.

Give Your Dog A Bone

Grow Your Pups with Bones: The BARF Program For breeding Healthy Dogs And Eliminating Skeletal Disease

Here is a good online resource if you are looking to get started feeding your dog a raw diet…

RAW Food amount calculator – How much to feed

7 Vets Give The Health Benefits of Raw Feeding for Dogs…

Watch video and check out article linked below on the dangers of commercial pet foods and myths about feeding raw…

Some other RAW feeding videos I recommend below…

Is It Expensive To Feed Your Dog RAW Foods?

Does RAW food make dogs aggressive?

Guide to feeding dogs RAW food

How to feed your dog RAW food

How to feed your puppy RAW food

***Here is a playlist of 100+ videos of my dogs and puppies eating various things on the raw diet…

***Here are my channels top 3 videos…

This Is What Happens When You Feed RAW food To Dogs!!!
2,267,841 views

This Is What Happens When You Feed Cucumber To Dogs!!!
444,170 view

ANTHEM of an OUTLAW – Apalachee Don (featuring BIG Chuk)
419,245 views

*** New Video series ***
Food Aggression in Puppies

!!! NEW * Blizzard of Oz Playlist !!!

*Visit my Instagram:

*****Music used in the background of this video from CO.AG Music:

Sinister Dark Ambient Background Music – Dark Rage